Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
Lancaster Opens $7 Million Position in 10x Genomics (TXG)
12:25pm, Friday, 24'th Oct 2025
Lancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million. 10x Genomics, a new holding for the investment manager, now accounts for 3.1% of its AUM.
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last?
06:21am, Tuesday, 21'st Oct 2025
10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
12:30pm, Monday, 20'th Oct 2025
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader
Blue Trust Inc. Raises Holdings in 10x Genomics $TXG
03:40am, Sunday, 19'th Oct 2025
Blue Trust Inc. increased its position in shares of 10x Genomics (NASDAQ: TXG) by 48.1% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
12:05pm, Friday, 17'th Oct 2025
From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.
10x Genomics (TXG) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Thursday, 16'th Oct 2025
10x Genomics (TXG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 09'th Oct 2025
PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ende
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
08:00am, Thursday, 09'th Oct 2025
SEATTLE--(BUSINESS WIRE)--Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent.
10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
02:14pm, Wednesday, 10'th Sep 2025
10x Genomics, Inc. (NASDAQ:TXG ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Serge Saxonov - Co-Founder, CEO & Director Conference Call
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
09:00am, Tuesday, 09'th Sep 2025
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedu
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
04:05pm, Wednesday, 27'th Aug 2025
PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate
2 Growth Stocks Cathie Wood Is Buying Non-Stop
10:26am, Thursday, 21'st Aug 2025
Cathie Wood is most known for her bold, tech-first investing.
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
09:00am, Tuesday, 19'th Aug 2025
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif. ,
5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions
08:45am, Monday, 11'th Aug 2025
Tsakos Energy Navigation, 10x Genomics, Pan American Silver, Wolverine World Wide, and Interface top an efficiency-driven stock screen.
10x Genomics, Inc. (TXG) Q2 2025 Earnings Call Transcript
04:13am, Saturday, 09'th Aug 2025
10x Genomics, Inc. (NASDAQ:TXG ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Adam S. Taich - CFO, Treasurer, Principal Financial Officer & Principal Accounting Offi
